默沙东据报接近以约100亿美元收购维罗纳制药

老虎资讯综合
09 Jul

据英国《金融时报》周三报道, 默沙东 (Merck,)正接近达成一项价值约100亿美元的交易,收购专注于肺部疾病的生物技术公司 维罗纳制药 (Verona Pharma)。

报道援引三位知情人士消息称,默沙东将为Verona的每股美国存托股份(ADS)支付107美元。

受消息影响,维罗纳制药夜盘升18%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10